第三代心臟輔助系統(tǒng)可以作為心臟衰竭患者心臟移植的永久替代治療方式。

VentrAssist系統(tǒng)是由Ventracor公司(Chatswood, NSW, Australia)生產(chǎn)的，是第三代左心室輔助設(shè)備(LVAD)，用于治療心臟衰竭患者以提高生活質(zhì)量。同時(shí)該系統(tǒng)還可以作為心臟移植的橋梁，還可能是通向康復(fù)的橋梁，從而給病變心臟一個(gè)恢復(fù)的機(jī)會(huì)。CE標(biāo)記臨床試驗(yàn)已經(jīng)完成，投放歐洲市場(chǎng)的各項(xiàng)準(zhǔn)備正在進(jìn)行之中。

 
By medinews.com staff writers
 
A third-generation cardiac-assist system has been designed as a permanent alternative to a heart transplant for patients suffering from heart failure.

The VentrAssist system, manufactured by Ventracor (Chatswood, NSW, Australia), is a third-generation left-ventricle-assist device (LVAD) system designed to provide patients suffering from heart failure with better quality of life. It can also be used as a bridge to heart transplant and possibly as a bridge to recovery, where it may allow a deteriorating heart an opportunity to recuperate. The CE Mark trial has been completed, and preparations are underway for a European market launch.